EFFECTS OF VIRTUAL REALITY WITH MOTOR IMAGERY TECHNIQUES IN ADDITION TO ROUTINE PHYSICAL THERAPY IN PATIENTS WITH PARKINSON’S DISEASE: A RANDOMIZED CONTROLLED TRIA

Phase 1

Not yet recruiting

• Conditions: PARKINSON’S DISEASE.; Parkinson's disease, virtual reality, motor imagery, balance, motor function, activities of daily living

• Registration Number: IRCT20200221046567N1
• Lead Sponsor: niversity of Lahore

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

?Idiopathic Parkinson’s disease ?Modified Hoehn and Yahr (H&Y) Stage-1 to Stage-3 ?Between the ages of 50 and 80 years of both gender ?Independent in transfers ?Score equal to or greater than 24 score on the Mini-Mental State Examination (MMSE) ?Previous lack of participation in balance or motor training

Exclusion Criteria

?History of any neurological conditions such as stroke, multiple sclerosis, epilepsy other than Parkinson’s disease ?History of orthopedic issues such as pain, fracture or lower limb pathology ?History of visual abnormalities?History of any chronic or cardiovascular pathology that can interfere with the transfer procedure or can affect the training sessions ?The participants having severe dyskinesia’s or on-off” phases ?Previous history of surgery for PD. ?History of Virtual games used in past 3 months ?Virtual game phobia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Balance. Timepoint: before intervention and 6, 12 week and after one month of intervention. Method of measurement: Berg Balance Scale and Activities specific Balance Confidence Scale.;Motor Function. Timepoint: before intervention and 6, 12 week and after one month of intervention. Method of measurement: Unified Parkinson’s Disease Rating Scale (UPDRS) (Part-III).;Activities of Daily livings. Timepoint: before intervention and 6, 12 week and after one month of intervention. Method of measurement: Unified Parkinson’s Disease Rating Scale (Part-II).